Daily Care News for October 26, 2022
advertisement
- Increased Screening, Education Levels Could Decrease Risk of DKA at T1D Onset in Pediatric Diabetes
- Hands of People With Diabetes More Often Affected by Trigger Finger
- CGM ‘becoming standard of care’ in diabetes management, with or without insulin use
- Improved Glycemia and Quality of Life Among Loop Users: Analysis of Real-world Data From a Single Center
- Sodium-glucose co-transporter-2 inhibitors in Type 1 Diabetes: A Scoping Review
- Efficacy of Control- IQ Technology in a General Endocrine Clinic
- Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM (Full text HTML, PDF)
- Learning experience design of an mHealth self-management intervention for adolescents with type 1 diabetes
- Effect of obesity and excessive body fat on glycaemic control in paediatric type 1 diabetes
- Racial and Ethnic Cardiometabolic Risk Disparities in the T1D Exchange Clinic Registry Cohort
- Neurodegeneration of the cornea and retina in patients with type 1 diabetes without clinical evidence of diabetic retinopathy (Full text HTML, PDF)
- Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications (Full text HTML, PDF)
- Sudden Cardiac Death in Patients With Type 1 Versus Type 2 Diabetes
- Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study (Full text HTML, PDF)
- Choice of Bariatric Surgery in Patients with Obesity and Type 1 Diabetes Mellitus? an Up-to-Date Systematic Review
- Diabetes mellitus and the risk of post-acute COVID-19 hospitalizations – a nationwide cohort study
- Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes being under regular diabetes care
- Utility of Plasma Beta-Hydroxybutyrate to Define Resolution of Diabetic Ketoacidosis
- Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
- CGM-based Time-in-Range Using Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Type 1 Diabetes: The Head-to-Head Randomized Controlled InRange Trial
- Sex differences in body composition in youth with type 1 diabetes and its predictive value in cardiovascular disease risk assessment
- The incidence of childhood-onset type 1 diabetes, time trends and association with the population composition in Sweden: a 40 year follow-up
- Baseline risk markers and visit-to-visit variability in relation to kidney outcomes – A post-hoc analysis of the PERL study
- Modified E-Delphi Process for Selection of Patient Reported Outcome Measures for Children and Families with Type-1 Diabetes using Continuous Glucose Monitors
- Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis
- Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis (Full text HTML, PDF)
- Nutritional intake when cycling under racing and training conditions in professional male cyclists with type 1 diabetes
- Efficacy of insulin dosing algorithms for high-fat high-protein mixed meals to control postprandial glycemic excursions in people living with type 1 diabetes: A systematic review and meta-analysis
- Continuous glucose monitoring use increasing among young people, linked to lower HbA1c
- Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
